332 related articles for article (PubMed ID: 25711464)
21. Iron Overload in Children with Leukemia Receiving Multiple Blood Transfusions.
Nair M; Kuttath V; Nair AR; Rajeswari B; Chellappan G; Thankamony P; Parukkutty K
Indian Pediatr; 2018 Nov; 55(11):962-965. PubMed ID: 30587644
[TBL] [Abstract][Full Text] [Related]
22. Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.
Wilson SR; Sears M; Williams E; Drapekin J; Sivakumar I; Padrino S; Desai PC; Hager W; Manwani D; Clay LJ; Field JJ; Kanter J; Cohen AJ; Saif Ur Rehman S; Lanzkron S; Little JA;
Br J Haematol; 2021 Dec; 195(5):e157-e160. PubMed ID: 34423416
[No Abstract] [Full Text] [Related]
23. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.
Kalpatthi R; Peters B; Kane I; Holloman D; Rackoff E; Disco D; Jackson S; Laver JH; Abboud MR
Pediatr Blood Cancer; 2010 Dec; 55(7):1338-42. PubMed ID: 20981690
[TBL] [Abstract][Full Text] [Related]
24. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
[TBL] [Abstract][Full Text] [Related]
25. Study of gonadal hormones in Egyptian female children with sickle cell anemia in correlation with iron overload: Single center study.
Hagag AA; El-Farargy MS; Elrefaey S; Abo El-enein AM
Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):1-7. PubMed ID: 26684919
[TBL] [Abstract][Full Text] [Related]
26. A pilot study of manual chronic partial exchange transfusion in children with sickle disease.
Aloni MN; Lê PQ; Heijmans C; Huybrechts S; Devalck C; Azzi N; Ngalula-Mujinga M; Ferster A
Hematology; 2015 Jun; 20(5):284-8. PubMed ID: 25133935
[TBL] [Abstract][Full Text] [Related]
27. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between red blood cell transfusion volume and posttransfusional iron overload in hematological diseases].
Ashida T; Kawano A; Yamada E; Ide D; Sugano C; Kato Y; Tsubakimoto Y; Ito S; Mine Y; Fujita M; Kanemitsu Y; Morishima Y; Morita Y; Tanaka H; Shimada T; Kawanishi K; Miyatake J; Tatsumi Y; Matsumura I
Rinsho Ketsueki; 2013 Apr; 54(4):365-9. PubMed ID: 23666218
[TBL] [Abstract][Full Text] [Related]
29. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.
Harmatz P; Butensky E; Quirolo K; Williams R; Ferrell L; Moyer T; Golden D; Neumayr L; Vichinsky E
Blood; 2000 Jul; 96(1):76-9. PubMed ID: 10891433
[TBL] [Abstract][Full Text] [Related]
30. Serum ferritin and total units transfused for assessing iron overload in adults with sickle cell disease.
Drasar E; Vasavda N; Igbineweka N; Awogbade M; Allman M; Thein SL
Br J Haematol; 2012 Jun; 157(5):645-7. PubMed ID: 22332939
[No Abstract] [Full Text] [Related]
31. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and management of iron overload in 631 patients with chronic transfusion dependency: results from a multicentre, observational study.
Cid J; Palomera L; Díaz M; Zamora C; Solano F
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s119-23. PubMed ID: 23522894
[TBL] [Abstract][Full Text] [Related]
33. Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors.
Tantiworawit A; Charoenkwan P; Hantrakool S; Choeyprasert W; Sivasomboon C; Sanguansermsri T
Int J Hematol; 2016 Jun; 103(6):643-8. PubMed ID: 27052211
[TBL] [Abstract][Full Text] [Related]
34. Children with HbSβ
Day ME; Rodeghier M; DeBaun MR
Pediatr Blood Cancer; 2018 Nov; 65(11):e27352. PubMed ID: 30094930
[TBL] [Abstract][Full Text] [Related]
35. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
Kim YR; Kim JS; Cheong JW; Song JW; Min YH
Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
[TBL] [Abstract][Full Text] [Related]
36. Burden of iron overload among non-chronically blood transfused preschool children with sickle cell anaemia.
Olufemi AS; Folashade AA; Adetutu OT
Afr Health Sci; 2021 Jun; 21(2):753-758. PubMed ID: 34795732
[TBL] [Abstract][Full Text] [Related]
37. Iron Overload in Survivors of Childhood Cancer.
Trovillion EM; Schubert L; Dietz AC
J Pediatr Hematol Oncol; 2018 Jul; 40(5):396-400. PubMed ID: 28562518
[TBL] [Abstract][Full Text] [Related]
38. The dangers of iron overload: bring in the iron police.
Lambing A; Kachalsky E; Mueller ML
J Am Acad Nurse Pract; 2012 Apr; 24(4):175-83. PubMed ID: 22486832
[TBL] [Abstract][Full Text] [Related]
39. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
[TBL] [Abstract][Full Text] [Related]
40. Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels.
Karam LB; Disco D; Jackson SM; Lewin D; McKie V; Baker RD; Baker SS; Laver JH; Nietert PJ; Abboud MR
Pediatr Blood Cancer; 2008 Jan; 50(1):62-5. PubMed ID: 17457853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
